nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.25	1	CiPCiCtD
Methylprednisolone—Prednisone—prostate cancer	0.166	1	CrCtD
Methylprednisolone—osteoarthritis—Prednisone—prostate cancer	0.119	1	CpDpCtD
Methylprednisolone—NR3C1—prostate cancer	0.0692	0.633	CbGaD
Methylprednisolone—CYP3A4—prostate cancer	0.0401	0.367	CbGaD
Methylprednisolone—Exemestane—Estrone—prostate cancer	0.0262	0.175	CrCrCtD
Methylprednisolone—Exemestane—Conjugated Estrogens—prostate cancer	0.0231	0.154	CrCrCtD
Methylprednisolone—NR3C1—Prednisone—prostate cancer	0.0143	0.111	CbGbCtD
Methylprednisolone—Testolactone—Estrone—prostate cancer	0.0137	0.0914	CrCrCtD
Methylprednisolone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0128	0.0997	CbGbCtD
Methylprednisolone—ABCB1—Estramustine—prostate cancer	0.0104	0.0813	CbGbCtD
Methylprednisolone—ABCB1—Cabazitaxel—prostate cancer	0.00688	0.0536	CbGbCtD
Methylprednisolone—Exemestane—Prednisone—prostate cancer	0.00682	0.0454	CrCrCtD
Methylprednisolone—CYP3A4—Bicalutamide—prostate cancer	0.00672	0.0524	CbGbCtD
Methylprednisolone—ABCB1—Estrone—prostate cancer	0.00672	0.0524	CbGbCtD
Methylprednisolone—CYP3A4—Estramustine—prostate cancer	0.00625	0.0487	CbGbCtD
Methylprednisolone—ABCB1—Ethinyl Estradiol—prostate cancer	0.00599	0.0467	CbGbCtD
Methylprednisolone—CYP3A4—Abiraterone—prostate cancer	0.00557	0.0434	CbGbCtD
Methylprednisolone—CYP3A4—Flutamide—prostate cancer	0.00557	0.0434	CbGbCtD
Methylprednisolone—Ciclesonide—Prednisone—prostate cancer	0.00453	0.0302	CrCrCtD
Methylprednisolone—ABCB1—Conjugated Estrogens—prostate cancer	0.0044	0.0343	CbGbCtD
Methylprednisolone—CYP3A4—Cabazitaxel—prostate cancer	0.00412	0.0321	CbGbCtD
Methylprednisolone—CYP3A4—Estrone—prostate cancer	0.00403	0.0314	CbGbCtD
Methylprednisolone—ABCB1—Mitoxantrone—prostate cancer	0.004	0.0312	CbGbCtD
Methylprednisolone—ABCB1—Estradiol—prostate cancer	0.00386	0.0301	CbGbCtD
Methylprednisolone—Hydrocortamate—Prednisone—prostate cancer	0.00379	0.0253	CrCrCtD
Methylprednisolone—Cortisone acetate—Prednisone—prostate cancer	0.00367	0.0245	CrCrCtD
Methylprednisolone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00359	0.028	CbGbCtD
Methylprednisolone—Testolactone—Prednisone—prostate cancer	0.00356	0.0238	CrCrCtD
Methylprednisolone—Prednicarbate—Prednisone—prostate cancer	0.00356	0.0238	CrCrCtD
Methylprednisolone—Fluocortolone—Prednisone—prostate cancer	0.00346	0.0231	CrCrCtD
Methylprednisolone—Alclometasone—Prednisone—prostate cancer	0.00336	0.0224	CrCrCtD
Methylprednisolone—ABCB1—Prednisone—prostate cancer	0.00332	0.0259	CbGbCtD
Methylprednisolone—Budesonide—Prednisone—prostate cancer	0.00327	0.0218	CrCrCtD
Methylprednisolone—Desonide—Prednisone—prostate cancer	0.00319	0.0213	CrCrCtD
Methylprednisolone—Diflorasone—Prednisone—prostate cancer	0.00319	0.0213	CrCrCtD
Methylprednisolone—Fludrocortisone—Prednisone—prostate cancer	0.00319	0.0213	CrCrCtD
Methylprednisolone—Flunisolide—Prednisone—prostate cancer	0.00319	0.0213	CrCrCtD
Methylprednisolone—Clobetasol propionate—Prednisone—prostate cancer	0.00319	0.0213	CrCrCtD
Methylprednisolone—Paramethasone—Prednisone—prostate cancer	0.00311	0.0207	CrCrCtD
Methylprednisolone—Desoximetasone—Prednisone—prostate cancer	0.00303	0.0202	CrCrCtD
Methylprednisolone—Loteprednol—Prednisone—prostate cancer	0.00296	0.0198	CrCrCtD
Methylprednisolone—Fluprednidene Acetate—Prednisone—prostate cancer	0.00296	0.0198	CrCrCtD
Methylprednisolone—Mometasone—Prednisone—prostate cancer	0.00296	0.0198	CrCrCtD
Methylprednisolone—Triamcinolone—Prednisone—prostate cancer	0.00296	0.0198	CrCrCtD
Methylprednisolone—Fluorometholone—Prednisone—prostate cancer	0.00296	0.0198	CrCrCtD
Methylprednisolone—Betamethasone—Prednisone—prostate cancer	0.00289	0.0193	CrCrCtD
Methylprednisolone—Dexamethasone—Prednisone—prostate cancer	0.00289	0.0193	CrCrCtD
Methylprednisolone—Rimexolone—Prednisone—prostate cancer	0.00289	0.0193	CrCrCtD
Methylprednisolone—Prednisolone—Prednisone—prostate cancer	0.00271	0.0181	CrCrCtD
Methylprednisolone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00263	0.0205	CbGbCtD
Methylprednisolone—Hydrocortisone—Prednisone—prostate cancer	0.0026	0.0173	CrCrCtD
Methylprednisolone—ABCB1—Etoposide—prostate cancer	0.00252	0.0196	CbGbCtD
Methylprednisolone—CYP3A4—Mitoxantrone—prostate cancer	0.0024	0.0187	CbGbCtD
Methylprednisolone—CYP3A4—Estradiol—prostate cancer	0.00231	0.018	CbGbCtD
Methylprednisolone—ABCB1—Docetaxel—prostate cancer	0.00231	0.018	CbGbCtD
Methylprednisolone—CYP3A4—Prednisone—prostate cancer	0.00199	0.0155	CbGbCtD
Methylprednisolone—ABCB1—Doxorubicin—prostate cancer	0.00172	0.0134	CbGbCtD
Methylprednisolone—CYP3A4—Etoposide—prostate cancer	0.00151	0.0118	CbGbCtD
Methylprednisolone—CYP3A4—Docetaxel—prostate cancer	0.00138	0.0108	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—prostate cancer	0.00103	0.00803	CbGbCtD
Methylprednisolone—NR3C1—urine—prostate cancer	0.000452	0.208	CbGeAlD
Methylprednisolone—CYP3A4—urine—prostate cancer	0.000342	0.157	CbGeAlD
Methylprednisolone—NR3C1—prostate gland—prostate cancer	0.000162	0.0746	CbGeAlD
Methylprednisolone—NR3C1—seminal vesicle—prostate cancer	0.000137	0.0631	CbGeAlD
Methylprednisolone—NR3C1—epithelium—prostate cancer	0.000119	0.0548	CbGeAlD
Methylprednisolone—NR3C1—renal system—prostate cancer	0.000111	0.0509	CbGeAlD
Methylprednisolone—NR3C1—urethra—prostate cancer	0.000109	0.05	CbGeAlD
Methylprednisolone—ABCB1—prostate gland—prostate cancer	8.68e-05	0.04	CbGeAlD
Methylprednisolone—Medroxyprogesterone Acetate—HSD3B2—prostate cancer	8.54e-05	0.0538	CrCbGaD
Methylprednisolone—CYP3A4—renal system—prostate cancer	8.36e-05	0.0385	CbGeAlD
Methylprednisolone—NR3C1—bone marrow—prostate cancer	8.36e-05	0.0385	CbGeAlD
Methylprednisolone—ABCB1—seminal vesicle—prostate cancer	7.34e-05	0.0338	CbGeAlD
Methylprednisolone—NR3C1—testis—prostate cancer	7.14e-05	0.0329	CbGeAlD
Methylprednisolone—ABCB1—epithelium—prostate cancer	6.38e-05	0.0294	CbGeAlD
Methylprednisolone—ABCB1—renal system—prostate cancer	5.92e-05	0.0272	CbGeAlD
Methylprednisolone—ABCB1—urethra—prostate cancer	5.81e-05	0.0267	CbGeAlD
Methylprednisolone—NR3C1—lymph node—prostate cancer	5.18e-05	0.0238	CbGeAlD
Methylprednisolone—Medroxyprogesterone Acetate—AKR1C3—prostate cancer	4.73e-05	0.0298	CrCbGaD
Methylprednisolone—ABCB1—bone marrow—prostate cancer	4.47e-05	0.0206	CbGeAlD
Methylprednisolone—Exemestane—CYP19A1—prostate cancer	4.38e-05	0.0276	CrCbGaD
Methylprednisolone—Hydrocortisone—ANXA1—prostate cancer	4.38e-05	0.0276	CrCbGaD
Methylprednisolone—Testolactone—CYP19A1—prostate cancer	4.17e-05	0.0263	CrCbGaD
Methylprednisolone—Dexamethasone—CYP3A43—prostate cancer	4.12e-05	0.026	CrCbGaD
Methylprednisolone—ABCB1—testis—prostate cancer	3.82e-05	0.0176	CbGeAlD
Methylprednisolone—Difluprednate—NR3C1—prostate cancer	3.49e-05	0.022	CrCbGaD
Methylprednisolone—Clocortolone—NR3C1—prostate cancer	3.38e-05	0.0213	CrCbGaD
Methylprednisolone—Prednicarbate—NR3C1—prostate cancer	3.38e-05	0.0213	CrCbGaD
Methylprednisolone—Dexamethasone—ANXA1—prostate cancer	3.26e-05	0.0205	CrCbGaD
Methylprednisolone—Diflorasone—NR3C1—prostate cancer	3.2e-05	0.0202	CrCbGaD
Methylprednisolone—Desonide—NR3C1—prostate cancer	3.2e-05	0.0202	CrCbGaD
Methylprednisolone—Desoximetasone—NR3C1—prostate cancer	3.12e-05	0.0197	CrCbGaD
Methylprednisolone—Loteprednol—NR3C1—prostate cancer	3.08e-05	0.0194	CrCbGaD
Methylprednisolone—Fludrocortisone—AR—prostate cancer	3.04e-05	0.0192	CrCbGaD
Methylprednisolone—Medrysone—NR3C1—prostate cancer	2.83e-05	0.0179	CrCbGaD
Methylprednisolone—ABCB1—lymph node—prostate cancer	2.77e-05	0.0128	CbGeAlD
Methylprednisolone—Flurandrenolide—NR3C1—prostate cancer	2.73e-05	0.0172	CrCbGaD
Methylprednisolone—Flumethasone Pivalate—NR3C1—prostate cancer	2.69e-05	0.0169	CrCbGaD
Methylprednisolone—Halobetasol Propionate—NR3C1—prostate cancer	2.64e-05	0.0167	CrCbGaD
Methylprednisolone—Hydrocortamate—NR3C1—prostate cancer	2.64e-05	0.0167	CrCbGaD
Methylprednisolone—Cortisone acetate—NR3C1—prostate cancer	2.6e-05	0.0164	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—SHBG—prostate cancer	2.46e-05	0.0155	CrCbGaD
Methylprednisolone—Budesonide—NR3C1—prostate cancer	2.46e-05	0.0155	CrCbGaD
Methylprednisolone—Mometasone—NR3C1—prostate cancer	2.34e-05	0.0147	CrCbGaD
Methylprednisolone—Rimexolone—NR3C1—prostate cancer	2.31e-05	0.0146	CrCbGaD
Methylprednisolone—Fluocinonide—NR3C1—prostate cancer	2.18e-05	0.0137	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—AR—prostate cancer	2.15e-05	0.0136	CrCbGaD
Methylprednisolone—Fluocinolone Acetonide—NR3C1—prostate cancer	2.12e-05	0.0133	CrCbGaD
Methylprednisolone—Alclometasone—NR3C1—prostate cancer	2.12e-05	0.0133	CrCbGaD
Methylprednisolone—Clobetasol propionate—NR3C1—prostate cancer	2.06e-05	0.013	CrCbGaD
Methylprednisolone—Fludrocortisone—NR3C1—prostate cancer	2.06e-05	0.013	CrCbGaD
Methylprednisolone—Flunisolide—NR3C1—prostate cancer	2.06e-05	0.013	CrCbGaD
Methylprednisolone—Exemestane—CYP3A4—prostate cancer	2.05e-05	0.013	CrCbGaD
Methylprednisolone—Paramethasone—NR3C1—prostate cancer	2.04e-05	0.0128	CrCbGaD
Methylprednisolone—Ciclesonide—NR3C1—prostate cancer	2e-05	0.0126	CrCbGaD
Methylprednisolone—Fluorometholone—NR3C1—prostate cancer	1.99e-05	0.0125	CrCbGaD
Methylprednisolone—Fluticasone Propionate—CYP3A5—prostate cancer	1.94e-05	0.0122	CrCbGaD
Methylprednisolone—Dexamethasone—CYP17A1—prostate cancer	1.87e-05	0.0118	CrCbGaD
Methylprednisolone—Clobetasol propionate—CYP1A1—prostate cancer	1.87e-05	0.0118	CrCbGaD
Methylprednisolone—Prednisolone—CYP2A6—prostate cancer	1.76e-05	0.0111	CrCbGaD
Methylprednisolone—Hydrocortisone—SHBG—prostate cancer	1.74e-05	0.011	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—ESR1—prostate cancer	1.66e-05	0.0105	CrCbGaD
Methylprednisolone—Betamethasone—CYP19A1—prostate cancer	1.64e-05	0.0103	CrCbGaD
Methylprednisolone—Triamcinolone—NR3C1—prostate cancer	1.62e-05	0.0102	CrCbGaD
Methylprednisolone—Hydrocortamate—CYP3A4—prostate cancer	1.53e-05	0.00966	CrCbGaD
Methylprednisolone—Cortisone acetate—CYP3A4—prostate cancer	1.51e-05	0.00951	CrCbGaD
Methylprednisolone—Prednisone—NR3C1—prostate cancer	1.47e-05	0.00926	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—NR3C1—prostate cancer	1.46e-05	0.00921	CrCbGaD
Methylprednisolone—Fluticasone Propionate—NR3C1—prostate cancer	1.45e-05	0.00913	CrCbGaD
Methylprednisolone—Budesonide—CYP3A4—prostate cancer	1.42e-05	0.00898	CrCbGaD
Methylprednisolone—Hydrocortisone—CYP3A5—prostate cancer	1.39e-05	0.00874	CrCbGaD
Methylprednisolone—Prednisolone—NR3C1—prostate cancer	1.35e-05	0.00854	CrCbGaD
Methylprednisolone—Prednisone—CYP2C19—prostate cancer	1.34e-05	0.00844	CrCbGaD
Methylprednisolone—Betamethasone—NR3C1—prostate cancer	1.33e-05	0.00836	CrCbGaD
Methylprednisolone—Dexamethasone—CYP1B1—prostate cancer	1.3e-05	0.00818	CrCbGaD
Methylprednisolone—Alclometasone—CYP3A4—prostate cancer	1.23e-05	0.00774	CrCbGaD
Methylprednisolone—Infestation—Epirubicin—prostate cancer	1.2e-05	0.000206	CcSEcCtD
Methylprednisolone—Malnutrition—Prednisone—prostate cancer	1.2e-05	0.000206	CcSEcCtD
Methylprednisolone—Erythema—Prednisone—prostate cancer	1.2e-05	0.000206	CcSEcCtD
Methylprednisolone—Flunisolide—CYP3A4—prostate cancer	1.2e-05	0.00753	CrCbGaD
Methylprednisolone—Arthralgia—Docetaxel—prostate cancer	1.19e-05	0.000204	CcSEcCtD
Methylprednisolone—Myalgia—Docetaxel—prostate cancer	1.19e-05	0.000204	CcSEcCtD
Methylprednisolone—Loss of consciousness—Capecitabine—prostate cancer	1.18e-05	0.000204	CcSEcCtD
Methylprednisolone—Paramethasone—CYP3A4—prostate cancer	1.18e-05	0.00744	CrCbGaD
Methylprednisolone—Asthenia—Mitoxantrone—prostate cancer	1.18e-05	0.000203	CcSEcCtD
Methylprednisolone—Fatigue—Etoposide—prostate cancer	1.18e-05	0.000203	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Epirubicin—prostate cancer	1.18e-05	0.000202	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	1.18e-05	0.000202	CcSEcCtD
Methylprednisolone—Dizziness—Estradiol—prostate cancer	1.17e-05	0.0002	CcSEcCtD
Methylprednisolone—Hypertension—Capecitabine—prostate cancer	1.16e-05	0.0002	CcSEcCtD
Methylprednisolone—Ciclesonide—CYP3A4—prostate cancer	1.16e-05	0.00732	CrCbGaD
Methylprednisolone—Sweating—Epirubicin—prostate cancer	1.15e-05	0.000198	CcSEcCtD
Methylprednisolone—Fluorometholone—CYP3A4—prostate cancer	1.15e-05	0.00726	CrCbGaD
Methylprednisolone—Myalgia—Capecitabine—prostate cancer	1.15e-05	0.000197	CcSEcCtD
Methylprednisolone—Arthralgia—Capecitabine—prostate cancer	1.15e-05	0.000197	CcSEcCtD
Methylprednisolone—Confusional state—Docetaxel—prostate cancer	1.15e-05	0.000197	CcSEcCtD
Methylprednisolone—Anxiety—Capecitabine—prostate cancer	1.14e-05	0.000197	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	1.14e-05	0.000196	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Docetaxel—prostate cancer	1.14e-05	0.000195	CcSEcCtD
Methylprednisolone—Weight increased—Doxorubicin—prostate cancer	1.13e-05	0.000195	CcSEcCtD
Methylprednisolone—Discomfort—Capecitabine—prostate cancer	1.13e-05	0.000195	CcSEcCtD
Methylprednisolone—Infection—Docetaxel—prostate cancer	1.13e-05	0.000194	CcSEcCtD
Methylprednisolone—Feeling abnormal—Etoposide—prostate cancer	1.13e-05	0.000194	CcSEcCtD
Methylprednisolone—Diarrhoea—Mitoxantrone—prostate cancer	1.12e-05	0.000193	CcSEcCtD
Methylprednisolone—Vomiting—Estradiol—prostate cancer	1.12e-05	0.000193	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Etoposide—prostate cancer	1.12e-05	0.000192	CcSEcCtD
Methylprednisolone—Shock—Docetaxel—prostate cancer	1.12e-05	0.000192	CcSEcCtD
Methylprednisolone—Nervous system disorder—Docetaxel—prostate cancer	1.11e-05	0.000191	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Prednisone—prostate cancer	1.11e-05	0.000191	CcSEcCtD
Methylprednisolone—Rash—Estradiol—prostate cancer	1.11e-05	0.000191	CcSEcCtD
Methylprednisolone—Infestation—Doxorubicin—prostate cancer	1.11e-05	0.000191	CcSEcCtD
Methylprednisolone—Infestation NOS—Doxorubicin—prostate cancer	1.11e-05	0.000191	CcSEcCtD
Methylprednisolone—Dermatitis—Estradiol—prostate cancer	1.11e-05	0.000191	CcSEcCtD
Methylprednisolone—Confusional state—Capecitabine—prostate cancer	1.11e-05	0.000191	CcSEcCtD
Methylprednisolone—Tachycardia—Docetaxel—prostate cancer	1.11e-05	0.000191	CcSEcCtD
Methylprednisolone—Headache—Estradiol—prostate cancer	1.11e-05	0.00019	CcSEcCtD
Methylprednisolone—Skin disorder—Docetaxel—prostate cancer	1.1e-05	0.00019	CcSEcCtD
Methylprednisolone—Bradycardia—Epirubicin—prostate cancer	1.1e-05	0.000189	CcSEcCtD
Methylprednisolone—Angioedema—Prednisone—prostate cancer	1.1e-05	0.000189	CcSEcCtD
Methylprednisolone—Infection—Capecitabine—prostate cancer	1.09e-05	0.000188	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Doxorubicin—prostate cancer	1.09e-05	0.000187	CcSEcCtD
Methylprednisolone—Urticaria—Etoposide—prostate cancer	1.09e-05	0.000187	CcSEcCtD
Methylprednisolone—Haemoglobin—Epirubicin—prostate cancer	1.08e-05	0.000186	CcSEcCtD
Methylprednisolone—Malaise—Prednisone—prostate cancer	1.08e-05	0.000186	CcSEcCtD
Methylprednisolone—Shock—Capecitabine—prostate cancer	1.08e-05	0.000186	CcSEcCtD
Methylprednisolone—Rhinitis—Epirubicin—prostate cancer	1.08e-05	0.000186	CcSEcCtD
Methylprednisolone—Abdominal pain—Etoposide—prostate cancer	1.08e-05	0.000186	CcSEcCtD
Methylprednisolone—Nervous system disorder—Capecitabine—prostate cancer	1.08e-05	0.000185	CcSEcCtD
Methylprednisolone—Vertigo—Prednisone—prostate cancer	1.08e-05	0.000185	CcSEcCtD
Methylprednisolone—Haemorrhage—Epirubicin—prostate cancer	1.08e-05	0.000185	CcSEcCtD
Methylprednisolone—Syncope—Prednisone—prostate cancer	1.08e-05	0.000185	CcSEcCtD
Methylprednisolone—Tachycardia—Capecitabine—prostate cancer	1.07e-05	0.000184	CcSEcCtD
Methylprednisolone—Skin disorder—Capecitabine—prostate cancer	1.07e-05	0.000184	CcSEcCtD
Methylprednisolone—Sweating—Doxorubicin—prostate cancer	1.07e-05	0.000183	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Capecitabine—prostate cancer	1.06e-05	0.000183	CcSEcCtD
Methylprednisolone—Hypotension—Docetaxel—prostate cancer	1.06e-05	0.000182	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Epirubicin—prostate cancer	1.06e-05	0.000182	CcSEcCtD
Methylprednisolone—Loss of consciousness—Prednisone—prostate cancer	1.06e-05	0.000181	CcSEcCtD
Methylprednisolone—Nausea—Estradiol—prostate cancer	1.05e-05	0.00018	CcSEcCtD
Methylprednisolone—Vomiting—Mitoxantrone—prostate cancer	1.05e-05	0.00018	CcSEcCtD
Methylprednisolone—Convulsion—Prednisone—prostate cancer	1.04e-05	0.000179	CcSEcCtD
Methylprednisolone—Visual impairment—Epirubicin—prostate cancer	1.04e-05	0.000179	CcSEcCtD
Methylprednisolone—Hypertension—Prednisone—prostate cancer	1.04e-05	0.000178	CcSEcCtD
Methylprednisolone—Rash—Mitoxantrone—prostate cancer	1.04e-05	0.000178	CcSEcCtD
Methylprednisolone—Hydrocortisone—NR3C1—prostate cancer	1.04e-05	0.00653	CrCbGaD
Methylprednisolone—Dermatitis—Mitoxantrone—prostate cancer	1.04e-05	0.000178	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.04e-05	0.000178	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP3A5—prostate cancer	1.03e-05	0.00651	CrCbGaD
Methylprednisolone—Headache—Mitoxantrone—prostate cancer	1.03e-05	0.000177	CcSEcCtD
Methylprednisolone—Hypotension—Capecitabine—prostate cancer	1.03e-05	0.000177	CcSEcCtD
Methylprednisolone—Insomnia—Docetaxel—prostate cancer	1.03e-05	0.000177	CcSEcCtD
Methylprednisolone—Arthralgia—Prednisone—prostate cancer	1.02e-05	0.000176	CcSEcCtD
Methylprednisolone—Myalgia—Prednisone—prostate cancer	1.02e-05	0.000176	CcSEcCtD
Methylprednisolone—Paraesthesia—Docetaxel—prostate cancer	1.02e-05	0.000175	CcSEcCtD
Methylprednisolone—Anxiety—Prednisone—prostate cancer	1.02e-05	0.000175	CcSEcCtD
Methylprednisolone—Bradycardia—Doxorubicin—prostate cancer	1.02e-05	0.000175	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.02e-05	0.000174	CcSEcCtD
Methylprednisolone—Discomfort—Prednisone—prostate cancer	1.01e-05	0.000174	CcSEcCtD
Methylprednisolone—Eye disorder—Epirubicin—prostate cancer	1.01e-05	0.000173	CcSEcCtD
Methylprednisolone—Hypersensitivity—Etoposide—prostate cancer	1.01e-05	0.000173	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—prostate cancer	1e-05	0.000172	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Capecitabine—prostate cancer	1e-05	0.000172	CcSEcCtD
Methylprednisolone—Cardiac disorder—Epirubicin—prostate cancer	1e-05	0.000172	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—prostate cancer	1e-05	0.000172	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP2A6—prostate cancer	1e-05	0.00631	CrCbGaD
Methylprednisolone—Dyspepsia—Docetaxel—prostate cancer	1e-05	0.000172	CcSEcCtD
Methylprednisolone—Haemorrhage—Doxorubicin—prostate cancer	9.98e-06	0.000172	CcSEcCtD
Methylprednisolone—Insomnia—Capecitabine—prostate cancer	9.95e-06	0.000171	CcSEcCtD
Methylprednisolone—Paraesthesia—Capecitabine—prostate cancer	9.88e-06	0.00017	CcSEcCtD
Methylprednisolone—Asthenia—Etoposide—prostate cancer	9.81e-06	0.000169	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Doxorubicin—prostate cancer	9.81e-06	0.000169	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Prednisone—prostate cancer	9.8e-06	0.000168	CcSEcCtD
Methylprednisolone—Fatigue—Docetaxel—prostate cancer	9.8e-06	0.000168	CcSEcCtD
Methylprednisolone—Angiopathy—Epirubicin—prostate cancer	9.79e-06	0.000168	CcSEcCtD
Methylprednisolone—Nausea—Mitoxantrone—prostate cancer	9.76e-06	0.000168	CcSEcCtD
Methylprednisolone—Immune system disorder—Epirubicin—prostate cancer	9.74e-06	0.000167	CcSEcCtD
Methylprednisolone—Infection—Prednisone—prostate cancer	9.74e-06	0.000167	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Epirubicin—prostate cancer	9.72e-06	0.000167	CcSEcCtD
Methylprednisolone—Dyspepsia—Capecitabine—prostate cancer	9.68e-06	0.000166	CcSEcCtD
Methylprednisolone—Pruritus—Etoposide—prostate cancer	9.67e-06	0.000166	CcSEcCtD
Methylprednisolone—Shock—Prednisone—prostate cancer	9.64e-06	0.000166	CcSEcCtD
Methylprednisolone—Arrhythmia—Epirubicin—prostate cancer	9.64e-06	0.000166	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—prostate cancer	9.62e-06	0.000165	CcSEcCtD
Methylprednisolone—Nervous system disorder—Prednisone—prostate cancer	9.61e-06	0.000165	CcSEcCtD
Methylprednisolone—Tachycardia—Prednisone—prostate cancer	9.56e-06	0.000164	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP19A1—prostate cancer	9.53e-06	0.006	CrCbGaD
Methylprednisolone—Skin disorder—Prednisone—prostate cancer	9.52e-06	0.000164	CcSEcCtD
Methylprednisolone—Fatigue—Capecitabine—prostate cancer	9.48e-06	0.000163	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Prednisone—prostate cancer	9.47e-06	0.000163	CcSEcCtD
Methylprednisolone—Mental disorder—Epirubicin—prostate cancer	9.45e-06	0.000162	CcSEcCtD
Methylprednisolone—Erythema—Epirubicin—prostate cancer	9.39e-06	0.000161	CcSEcCtD
Methylprednisolone—Malnutrition—Epirubicin—prostate cancer	9.39e-06	0.000161	CcSEcCtD
Methylprednisolone—Triamcinolone—CYP3A4—prostate cancer	9.39e-06	0.00592	CrCbGaD
Methylprednisolone—Feeling abnormal—Docetaxel—prostate cancer	9.36e-06	0.000161	CcSEcCtD
Methylprednisolone—Diarrhoea—Etoposide—prostate cancer	9.35e-06	0.000161	CcSEcCtD
Methylprednisolone—Eye disorder—Doxorubicin—prostate cancer	9.33e-06	0.00016	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Docetaxel—prostate cancer	9.29e-06	0.00016	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—prostate cancer	9.26e-06	0.000159	CcSEcCtD
Methylprednisolone—Triamcinolone—PTGS2—prostate cancer	9.19e-06	0.00579	CrCbGaD
Methylprednisolone—Feeling abnormal—Capecitabine—prostate cancer	9.07e-06	0.000156	CcSEcCtD
Methylprednisolone—Angiopathy—Doxorubicin—prostate cancer	9.06e-06	0.000156	CcSEcCtD
Methylprednisolone—Dizziness—Etoposide—prostate cancer	9.04e-06	0.000155	CcSEcCtD
Methylprednisolone—Immune system disorder—Doxorubicin—prostate cancer	9.02e-06	0.000155	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Capecitabine—prostate cancer	9e-06	0.000155	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—prostate cancer	9e-06	0.000155	CcSEcCtD
Methylprednisolone—Abdominal pain—Docetaxel—prostate cancer	8.98e-06	0.000154	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Prednisone—prostate cancer	8.93e-06	0.000153	CcSEcCtD
Methylprednisolone—Arrhythmia—Doxorubicin—prostate cancer	8.92e-06	0.000153	CcSEcCtD
Methylprednisolone—Insomnia—Prednisone—prostate cancer	8.86e-06	0.000152	CcSEcCtD
Methylprednisolone—Paraesthesia—Prednisone—prostate cancer	8.8e-06	0.000151	CcSEcCtD
Methylprednisolone—Mental disorder—Doxorubicin—prostate cancer	8.74e-06	0.00015	CcSEcCtD
Methylprednisolone—Urticaria—Capecitabine—prostate cancer	8.74e-06	0.00015	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Epirubicin—prostate cancer	8.71e-06	0.00015	CcSEcCtD
Methylprednisolone—Abdominal pain—Capecitabine—prostate cancer	8.7e-06	0.000149	CcSEcCtD
Methylprednisolone—Vomiting—Etoposide—prostate cancer	8.69e-06	0.000149	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—prostate cancer	8.69e-06	0.000149	CcSEcCtD
Methylprednisolone—Erythema—Doxorubicin—prostate cancer	8.69e-06	0.000149	CcSEcCtD
Methylprednisolone—Dyspepsia—Prednisone—prostate cancer	8.63e-06	0.000148	CcSEcCtD
Methylprednisolone—Rash—Etoposide—prostate cancer	8.62e-06	0.000148	CcSEcCtD
Methylprednisolone—Dermatitis—Etoposide—prostate cancer	8.61e-06	0.000148	CcSEcCtD
Methylprednisolone—Headache—Etoposide—prostate cancer	8.57e-06	0.000147	CcSEcCtD
Methylprednisolone—Prednisone—CYP3A4—prostate cancer	8.52e-06	0.00537	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—CYP3A4—prostate cancer	8.47e-06	0.00534	CrCbGaD
Methylprednisolone—Malaise—Epirubicin—prostate cancer	8.47e-06	0.000146	CcSEcCtD
Methylprednisolone—Fatigue—Prednisone—prostate cancer	8.45e-06	0.000145	CcSEcCtD
Methylprednisolone—Vertigo—Epirubicin—prostate cancer	8.44e-06	0.000145	CcSEcCtD
Methylprednisolone—Syncope—Epirubicin—prostate cancer	8.42e-06	0.000145	CcSEcCtD
Methylprednisolone—Fluticasone Propionate—CYP3A4—prostate cancer	8.39e-06	0.00529	CrCbGaD
Methylprednisolone—Hypersensitivity—Docetaxel—prostate cancer	8.37e-06	0.000144	CcSEcCtD
Methylprednisolone—Loss of consciousness—Epirubicin—prostate cancer	8.25e-06	0.000142	CcSEcCtD
Methylprednisolone—Asthenia—Docetaxel—prostate cancer	8.15e-06	0.00014	CcSEcCtD
Methylprednisolone—Convulsion—Epirubicin—prostate cancer	8.14e-06	0.00014	CcSEcCtD
Methylprednisolone—Nausea—Etoposide—prostate cancer	8.12e-06	0.00014	CcSEcCtD
Methylprednisolone—Hypertension—Epirubicin—prostate cancer	8.11e-06	0.000139	CcSEcCtD
Methylprednisolone—Hypersensitivity—Capecitabine—prostate cancer	8.11e-06	0.000139	CcSEcCtD
Methylprednisolone—Feeling abnormal—Prednisone—prostate cancer	8.08e-06	0.000139	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Doxorubicin—prostate cancer	8.06e-06	0.000139	CcSEcCtD
Methylprednisolone—Pruritus—Docetaxel—prostate cancer	8.04e-06	0.000138	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Prednisone—prostate cancer	8.01e-06	0.000138	CcSEcCtD
Methylprednisolone—Myalgia—Epirubicin—prostate cancer	7.99e-06	0.000137	CcSEcCtD
Methylprednisolone—Arthralgia—Epirubicin—prostate cancer	7.99e-06	0.000137	CcSEcCtD
Methylprednisolone—Anxiety—Epirubicin—prostate cancer	7.97e-06	0.000137	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	7.94e-06	0.000136	CcSEcCtD
Methylprednisolone—Discomfort—Epirubicin—prostate cancer	7.9e-06	0.000136	CcSEcCtD
Methylprednisolone—Asthenia—Capecitabine—prostate cancer	7.89e-06	0.000136	CcSEcCtD
Methylprednisolone—Prednisolone—CYP3A4—prostate cancer	7.85e-06	0.00495	CrCbGaD
Methylprednisolone—Malaise—Doxorubicin—prostate cancer	7.84e-06	0.000135	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—prostate cancer	7.81e-06	0.000134	CcSEcCtD
Methylprednisolone—Syncope—Doxorubicin—prostate cancer	7.79e-06	0.000134	CcSEcCtD
Methylprednisolone—Urticaria—Prednisone—prostate cancer	7.78e-06	0.000134	CcSEcCtD
Methylprednisolone—Pruritus—Capecitabine—prostate cancer	7.78e-06	0.000134	CcSEcCtD
Methylprednisolone—Diarrhoea—Docetaxel—prostate cancer	7.77e-06	0.000134	CcSEcCtD
Methylprednisolone—Abdominal pain—Prednisone—prostate cancer	7.75e-06	0.000133	CcSEcCtD
Methylprednisolone—Confusional state—Epirubicin—prostate cancer	7.73e-06	0.000133	CcSEcCtD
Methylprednisolone—Dexamethasone—NR3C1—prostate cancer	7.72e-06	0.00486	CrCbGaD
Methylprednisolone—Betamethasone—CYP3A4—prostate cancer	7.69e-06	0.00485	CrCbGaD
Methylprednisolone—Anaphylactic shock—Epirubicin—prostate cancer	7.66e-06	0.000132	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—prostate cancer	7.64e-06	0.000131	CcSEcCtD
Methylprednisolone—Infection—Epirubicin—prostate cancer	7.61e-06	0.000131	CcSEcCtD
Methylprednisolone—Shock—Epirubicin—prostate cancer	7.54e-06	0.00013	CcSEcCtD
Methylprednisolone—Betamethasone—PTGS2—prostate cancer	7.53e-06	0.00475	CrCbGaD
Methylprednisolone—Convulsion—Doxorubicin—prostate cancer	7.53e-06	0.000129	CcSEcCtD
Methylprednisolone—Diarrhoea—Capecitabine—prostate cancer	7.53e-06	0.000129	CcSEcCtD
Methylprednisolone—Nervous system disorder—Epirubicin—prostate cancer	7.52e-06	0.000129	CcSEcCtD
Methylprednisolone—Dizziness—Docetaxel—prostate cancer	7.51e-06	0.000129	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—prostate cancer	7.5e-06	0.000129	CcSEcCtD
Methylprednisolone—Tachycardia—Epirubicin—prostate cancer	7.48e-06	0.000129	CcSEcCtD
Methylprednisolone—Skin disorder—Epirubicin—prostate cancer	7.44e-06	0.000128	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Epirubicin—prostate cancer	7.41e-06	0.000127	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—prostate cancer	7.4e-06	0.000127	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—prostate cancer	7.4e-06	0.000127	CcSEcCtD
Methylprednisolone—Anxiety—Doxorubicin—prostate cancer	7.37e-06	0.000127	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	7.35e-06	0.000126	CcSEcCtD
Methylprednisolone—Discomfort—Doxorubicin—prostate cancer	7.31e-06	0.000126	CcSEcCtD
Methylprednisolone—Dizziness—Capecitabine—prostate cancer	7.27e-06	0.000125	CcSEcCtD
Methylprednisolone—Vomiting—Docetaxel—prostate cancer	7.22e-06	0.000124	CcSEcCtD
Methylprednisolone—Hypersensitivity—Prednisone—prostate cancer	7.22e-06	0.000124	CcSEcCtD
Methylprednisolone—Rash—Docetaxel—prostate cancer	7.16e-06	0.000123	CcSEcCtD
Methylprednisolone—Hypotension—Epirubicin—prostate cancer	7.16e-06	0.000123	CcSEcCtD
Methylprednisolone—Dermatitis—Docetaxel—prostate cancer	7.16e-06	0.000123	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—prostate cancer	7.15e-06	0.000123	CcSEcCtD
Methylprednisolone—Headache—Docetaxel—prostate cancer	7.12e-06	0.000122	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP2E1—prostate cancer	7.1e-06	0.00448	CrCbGaD
Methylprednisolone—Anaphylactic shock—Doxorubicin—prostate cancer	7.09e-06	0.000122	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—prostate cancer	7.05e-06	0.000121	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP2C19—prostate cancer	7.04e-06	0.00443	CrCbGaD
Methylprednisolone—Asthenia—Prednisone—prostate cancer	7.03e-06	0.000121	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP1A1—prostate cancer	7.01e-06	0.00442	CrCbGaD
Methylprednisolone—Vomiting—Capecitabine—prostate cancer	6.99e-06	0.00012	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.98e-06	0.00012	CcSEcCtD
Methylprednisolone—Shock—Doxorubicin—prostate cancer	6.98e-06	0.00012	CcSEcCtD
Methylprednisolone—Nervous system disorder—Doxorubicin—prostate cancer	6.95e-06	0.000119	CcSEcCtD
Methylprednisolone—Rash—Capecitabine—prostate cancer	6.94e-06	0.000119	CcSEcCtD
Methylprednisolone—Pruritus—Prednisone—prostate cancer	6.93e-06	0.000119	CcSEcCtD
Methylprednisolone—Insomnia—Epirubicin—prostate cancer	6.93e-06	0.000119	CcSEcCtD
Methylprednisolone—Dermatitis—Capecitabine—prostate cancer	6.93e-06	0.000119	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—prostate cancer	6.92e-06	0.000119	CcSEcCtD
Methylprednisolone—Headache—Capecitabine—prostate cancer	6.89e-06	0.000118	CcSEcCtD
Methylprednisolone—Skin disorder—Doxorubicin—prostate cancer	6.89e-06	0.000118	CcSEcCtD
Methylprednisolone—Paraesthesia—Epirubicin—prostate cancer	6.88e-06	0.000118	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Doxorubicin—prostate cancer	6.86e-06	0.000118	CcSEcCtD
Methylprednisolone—Nausea—Docetaxel—prostate cancer	6.75e-06	0.000116	CcSEcCtD
Methylprednisolone—Dyspepsia—Epirubicin—prostate cancer	6.75e-06	0.000116	CcSEcCtD
Methylprednisolone—Diarrhoea—Prednisone—prostate cancer	6.7e-06	0.000115	CcSEcCtD
Methylprednisolone—Hypotension—Doxorubicin—prostate cancer	6.63e-06	0.000114	CcSEcCtD
Methylprednisolone—Fatigue—Epirubicin—prostate cancer	6.61e-06	0.000114	CcSEcCtD
Methylprednisolone—Nausea—Capecitabine—prostate cancer	6.53e-06	0.000112	CcSEcCtD
Methylprednisolone—Dizziness—Prednisone—prostate cancer	6.48e-06	0.000111	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	6.46e-06	0.000111	CcSEcCtD
Methylprednisolone—Insomnia—Doxorubicin—prostate cancer	6.41e-06	0.00011	CcSEcCtD
Methylprednisolone—Paraesthesia—Doxorubicin—prostate cancer	6.37e-06	0.000109	CcSEcCtD
Methylprednisolone—Feeling abnormal—Epirubicin—prostate cancer	6.32e-06	0.000109	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Epirubicin—prostate cancer	6.27e-06	0.000108	CcSEcCtD
Methylprednisolone—Dyspepsia—Doxorubicin—prostate cancer	6.24e-06	0.000107	CcSEcCtD
Methylprednisolone—Vomiting—Prednisone—prostate cancer	6.23e-06	0.000107	CcSEcCtD
Methylprednisolone—Rash—Prednisone—prostate cancer	6.18e-06	0.000106	CcSEcCtD
Methylprednisolone—Dermatitis—Prednisone—prostate cancer	6.17e-06	0.000106	CcSEcCtD
Methylprednisolone—Headache—Prednisone—prostate cancer	6.14e-06	0.000105	CcSEcCtD
Methylprednisolone—Fatigue—Doxorubicin—prostate cancer	6.11e-06	0.000105	CcSEcCtD
Methylprednisolone—Urticaria—Epirubicin—prostate cancer	6.09e-06	0.000105	CcSEcCtD
Methylprednisolone—Abdominal pain—Epirubicin—prostate cancer	6.06e-06	0.000104	CcSEcCtD
Methylprednisolone—Hydrocortisone—CYP3A4—prostate cancer	6e-06	0.00378	CrCbGaD
Methylprednisolone—Feeling abnormal—Doxorubicin—prostate cancer	5.84e-06	0.0001	CcSEcCtD
Methylprednisolone—Nausea—Prednisone—prostate cancer	5.82e-06	0.0001	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—AOX1—prostate cancer	5.8e-06	0.000349	CbGpPWpGaD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—prostate cancer	5.8e-06	9.96e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	5.78e-06	0.000348	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	5.76e-06	0.000346	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Epirubicin—prostate cancer	5.65e-06	9.7e-05	CcSEcCtD
Methylprednisolone—Urticaria—Doxorubicin—prostate cancer	5.63e-06	9.68e-05	CcSEcCtD
Methylprednisolone—Abdominal pain—Doxorubicin—prostate cancer	5.61e-06	9.63e-05	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	5.6e-06	0.000337	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	5.51e-06	0.000331	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AMACR—prostate cancer	5.5e-06	0.000331	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP3A43—prostate cancer	5.5e-06	0.000331	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—DEGS1—prostate cancer	5.5e-06	0.000331	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SRD5A2—prostate cancer	5.5e-06	0.000331	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NAT1—prostate cancer	5.5e-06	0.000331	CbGpPWpGaD
Methylprednisolone—Asthenia—Epirubicin—prostate cancer	5.5e-06	9.45e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	5.44e-06	0.000327	CbGpPWpGaD
Methylprednisolone—Pruritus—Epirubicin—prostate cancer	5.42e-06	9.32e-05	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	5.38e-06	0.000324	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPS19—prostate cancer	5.38e-06	0.000324	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTM1—prostate cancer	5.36e-06	0.000323	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	5.31e-06	0.000319	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	5.29e-06	0.000318	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	5.26e-06	0.000316	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD17B1—prostate cancer	5.25e-06	0.000316	CbGpPWpGaD
Methylprednisolone—Diarrhoea—Epirubicin—prostate cancer	5.24e-06	9.01e-05	CcSEcCtD
Methylprednisolone—Hypersensitivity—Doxorubicin—prostate cancer	5.22e-06	8.98e-05	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—DNMT1—prostate cancer	5.14e-06	0.000309	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	5.1e-06	0.000306	CbGpPWpGaD
Methylprednisolone—Asthenia—Doxorubicin—prostate cancer	5.09e-06	8.74e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	5.08e-06	0.000306	CbGpPWpGaD
Methylprednisolone—Dizziness—Epirubicin—prostate cancer	5.07e-06	8.71e-05	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—NCOA2—prostate cancer	5.05e-06	0.000304	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HAO1—prostate cancer	5.02e-06	0.000302	CbGpPWpGaD
Methylprednisolone—Pruritus—Doxorubicin—prostate cancer	5.02e-06	8.62e-05	CcSEcCtD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	5.01e-06	0.000302	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	5e-06	0.000301	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—EZH2—prostate cancer	4.98e-06	0.000299	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PARP1—prostate cancer	4.87e-06	0.000293	CbGpPWpGaD
Methylprednisolone—Vomiting—Epirubicin—prostate cancer	4.87e-06	8.37e-05	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—prostate cancer	4.85e-06	8.34e-05	CcSEcCtD
Methylprednisolone—Rash—Epirubicin—prostate cancer	4.83e-06	8.3e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Epirubicin—prostate cancer	4.83e-06	8.3e-05	CcSEcCtD
Methylprednisolone—Headache—Epirubicin—prostate cancer	4.8e-06	8.25e-05	CcSEcCtD
Methylprednisolone—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	4.78e-06	0.000287	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.77e-06	0.000287	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	4.75e-06	0.000286	CbGpPWpGaD
Methylprednisolone—Dizziness—Doxorubicin—prostate cancer	4.69e-06	8.06e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	4.68e-06	0.000282	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HPGD—prostate cancer	4.68e-06	0.000281	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—B4GALT4—prostate cancer	4.68e-06	0.000281	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ESR2—prostate cancer	4.62e-06	0.000278	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HSPA1A—prostate cancer	4.62e-06	0.000278	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	4.62e-06	0.000278	CbGpPWpGaD
Methylprednisolone—Nausea—Epirubicin—prostate cancer	4.55e-06	7.82e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	4.51e-06	0.000271	CbGpPWpGaD
Methylprednisolone—Vomiting—Doxorubicin—prostate cancer	4.51e-06	7.75e-05	CcSEcCtD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.5e-06	0.000271	CbGpPWpGaD
Methylprednisolone—Dexamethasone—CYP3A4—prostate cancer	4.47e-06	0.00282	CrCbGaD
Methylprednisolone—Rash—Doxorubicin—prostate cancer	4.47e-06	7.68e-05	CcSEcCtD
Methylprednisolone—Dermatitis—Doxorubicin—prostate cancer	4.47e-06	7.68e-05	CcSEcCtD
Methylprednisolone—Headache—Doxorubicin—prostate cancer	4.44e-06	7.63e-05	CcSEcCtD
Methylprednisolone—ABCB1—Metabolism—TNFRSF21—prostate cancer	4.4e-06	0.000265	CbGpPWpGaD
Methylprednisolone—Dexamethasone—PTGS2—prostate cancer	4.38e-06	0.00276	CrCbGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.29e-06	0.000258	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP7B1—prostate cancer	4.28e-06	0.000257	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTAP—prostate cancer	4.28e-06	0.000257	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	4.27e-06	0.000257	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NCOA1—prostate cancer	4.25e-06	0.000256	CbGpPWpGaD
Methylprednisolone—Nausea—Doxorubicin—prostate cancer	4.21e-06	7.24e-05	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	4.19e-06	0.000252	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SULT1E1—prostate cancer	4.17e-06	0.000251	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SRD5A1—prostate cancer	4.17e-06	0.000251	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CSAD—prostate cancer	4.09e-06	0.000246	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CBR1—prostate cancer	4.09e-06	0.000246	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ADI1—prostate cancer	4.09e-06	0.000246	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TST—prostate cancer	4.09e-06	0.000246	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GRHL1—prostate cancer	4.09e-06	0.000246	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PSAT1—prostate cancer	4.09e-06	0.000246	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	4.08e-06	0.000245	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AR—prostate cancer	4.08e-06	0.000245	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RXRA—prostate cancer	4.04e-06	0.000243	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	4.04e-06	0.000243	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ACSL4—prostate cancer	3.98e-06	0.000239	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD17B3—prostate cancer	3.98e-06	0.000239	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	3.94e-06	0.000237	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	3.94e-06	0.000237	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ARG2—prostate cancer	3.81e-06	0.000229	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PHGDH—prostate cancer	3.81e-06	0.000229	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—UMPS—prostate cancer	3.81e-06	0.000229	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GRHPR—prostate cancer	3.8e-06	0.000229	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UGT2B17—prostate cancer	3.8e-06	0.000229	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UGT2B15—prostate cancer	3.8e-06	0.000229	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CKMT2—prostate cancer	3.8e-06	0.000229	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.79e-06	0.000228	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	3.75e-06	0.000226	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LDHB—prostate cancer	3.74e-06	0.000225	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SIRT1—prostate cancer	3.72e-06	0.000224	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP3A5—prostate cancer	3.67e-06	0.000221	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—VDR—prostate cancer	3.66e-06	0.00022	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	3.65e-06	0.00022	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	3.61e-06	0.000217	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MBTPS1—prostate cancer	3.58e-06	0.000215	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SULT2B1—prostate cancer	3.58e-06	0.000215	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTM3—prostate cancer	3.58e-06	0.000215	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NAGLU—prostate cancer	3.58e-06	0.000215	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—RFK—prostate cancer	3.58e-06	0.000215	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PGAM2—prostate cancer	3.58e-06	0.000215	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AOX1—prostate cancer	3.58e-06	0.000215	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	3.55e-06	0.000214	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PDHA1—prostate cancer	3.54e-06	0.000213	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA3—prostate cancer	3.54e-06	0.000213	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—UCP3—prostate cancer	3.54e-06	0.000213	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TCN2—prostate cancer	3.54e-06	0.000213	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP3A43—prostate cancer	3.39e-06	0.000204	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AMACR—prostate cancer	3.39e-06	0.000204	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—DEGS1—prostate cancer	3.39e-06	0.000204	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SRD5A2—prostate cancer	3.39e-06	0.000204	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NAT1—prostate cancer	3.39e-06	0.000204	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD3B1—prostate cancer	3.38e-06	0.000203	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC22A3—prostate cancer	3.38e-06	0.000203	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ERCC2—prostate cancer	3.35e-06	0.000202	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	3.27e-06	0.000197	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	3.26e-06	0.000196	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA4—prostate cancer	3.24e-06	0.000195	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TBXAS1—prostate cancer	3.24e-06	0.000195	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD17B1—prostate cancer	3.23e-06	0.000194	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	3.2e-06	0.000192	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA2—prostate cancer	3.16e-06	0.00019	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SULT1A1—prostate cancer	3.12e-06	0.000188	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCG5—prostate cancer	3.12e-06	0.000188	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARA—prostate cancer	3.09e-06	0.000186	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTA1—prostate cancer	3.05e-06	0.000183	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	3.02e-06	0.000182	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	3.02e-06	0.000182	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD3B2—prostate cancer	3.01e-06	0.000181	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTO1—prostate cancer	3.01e-06	0.000181	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NAT2—prostate cancer	3.01e-06	0.000181	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLCB2—prostate cancer	2.89e-06	0.000174	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LRP2—prostate cancer	2.89e-06	0.000174	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2C18—prostate cancer	2.89e-06	0.000174	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—B4GALT4—prostate cancer	2.88e-06	0.000173	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HPGD—prostate cancer	2.88e-06	0.000173	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—P4HB—prostate cancer	2.83e-06	0.00017	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ESR1—prostate cancer	2.8e-06	0.000168	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	2.78e-06	0.000167	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC22A1—prostate cancer	2.76e-06	0.000166	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.76e-06	0.000166	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TNFRSF21—prostate cancer	2.71e-06	0.000163	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SULT2A1—prostate cancer	2.69e-06	0.000162	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	2.69e-06	0.000162	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MED12—prostate cancer	2.64e-06	0.000159	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTAP—prostate cancer	2.64e-06	0.000159	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP7B1—prostate cancer	2.64e-06	0.000159	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GNG5—prostate cancer	2.62e-06	0.000158	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SULT1E1—prostate cancer	2.57e-06	0.000154	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SRD5A1—prostate cancer	2.57e-06	0.000154	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOA3—prostate cancer	2.53e-06	0.000152	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—CREBBP—prostate cancer	2.45e-06	0.000148	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ACSL4—prostate cancer	2.45e-06	0.000147	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD17B3—prostate cancer	2.45e-06	0.000147	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HPGDS—prostate cancer	2.41e-06	0.000145	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2C19—prostate cancer	2.39e-06	0.000144	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UMPS—prostate cancer	2.35e-06	0.000141	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PHGDH—prostate cancer	2.35e-06	0.000141	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ARG2—prostate cancer	2.35e-06	0.000141	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTT1—prostate cancer	2.34e-06	0.000141	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ACHE—prostate cancer	2.34e-06	0.000141	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2A6—prostate cancer	2.31e-06	0.000139	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LDHB—prostate cancer	2.3e-06	0.000139	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SERPINE1—prostate cancer	2.3e-06	0.000138	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.27e-06	0.000136	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.26e-06	0.000136	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKR1C3—prostate cancer	2.25e-06	0.000135	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PRKACB—prostate cancer	2.24e-06	0.000134	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP17A1—prostate cancer	2.21e-06	0.000133	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.19e-06	0.000132	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PDHA1—prostate cancer	2.18e-06	0.000131	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UCP3—prostate cancer	2.18e-06	0.000131	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TCN2—prostate cancer	2.18e-06	0.000131	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA3—prostate cancer	2.18e-06	0.000131	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOA2—prostate cancer	2.11e-06	0.000127	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.08e-06	0.000125	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.08e-06	0.000125	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC5A5—prostate cancer	2.01e-06	0.000121	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA4—prostate cancer	2e-06	0.00012	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TBXAS1—prostate cancer	2e-06	0.00012	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2E1—prostate cancer	1.96e-06	0.000118	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA2—prostate cancer	1.95e-06	0.000117	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NQO1—prostate cancer	1.94e-06	0.000117	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCG5—prostate cancer	1.92e-06	0.000116	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.92e-06	0.000116	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TH—prostate cancer	1.91e-06	0.000115	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP3A4—prostate cancer	1.89e-06	0.000114	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTA1—prostate cancer	1.88e-06	0.000113	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP1B1—prostate cancer	1.86e-06	0.000112	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.86e-06	0.000112	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTO1—prostate cancer	1.86e-06	0.000112	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NAT2—prostate cancer	1.86e-06	0.000112	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GGT1—prostate cancer	1.8e-06	0.000108	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLCB2—prostate cancer	1.78e-06	0.000107	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.78e-06	0.000107	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LRP2—prostate cancer	1.78e-06	0.000107	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOA1—prostate cancer	1.78e-06	0.000107	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP19A1—prostate cancer	1.75e-06	0.000105	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—P4HB—prostate cancer	1.75e-06	0.000105	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.7e-06	0.000102	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—RXRA—prostate cancer	1.69e-06	0.000102	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.66e-06	9.96e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MED12—prostate cancer	1.63e-06	9.79e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—COMT—prostate cancer	1.63e-06	9.79e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTP1—prostate cancer	1.62e-06	9.74e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GNG5—prostate cancer	1.62e-06	9.72e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ITPR1—prostate cancer	1.59e-06	9.59e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOA3—prostate cancer	1.56e-06	9.36e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TYMS—prostate cancer	1.51e-06	9.06e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTM1—prostate cancer	1.49e-06	8.95e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HPGDS—prostate cancer	1.48e-06	8.93e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.48e-06	8.87e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LPL—prostate cancer	1.46e-06	8.79e-05	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MYC—prostate cancer	1.46e-06	8.76e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ACHE—prostate cancer	1.44e-06	8.66e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTT1—prostate cancer	1.44e-06	8.66e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.42e-06	8.56e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP1A1—prostate cancer	1.41e-06	8.49e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ERCC2—prostate cancer	1.4e-06	8.42e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.38e-06	8.33e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PRKACB—prostate cancer	1.38e-06	8.28e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.36e-06	8.2e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTHFR—prostate cancer	1.32e-06	7.91e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOA2—prostate cancer	1.3e-06	7.81e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARA—prostate cancer	1.29e-06	7.76e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.24e-06	7.45e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CAV1—prostate cancer	1.21e-06	7.3e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.21e-06	7.28e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NQO1—prostate cancer	1.2e-06	7.2e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TH—prostate cancer	1.18e-06	7.09e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.15e-06	6.9e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GGT1—prostate cancer	1.11e-06	6.68e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CG—prostate cancer	1.11e-06	6.65e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.09e-06	6.58e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.08e-06	6.49e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—INS—prostate cancer	1.05e-06	6.29e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—RXRA—prostate cancer	1.04e-06	6.26e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CREBBP—prostate cancer	1.02e-06	6.16e-05	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AKT1—prostate cancer	1.01e-06	6.07e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—COMT—prostate cancer	1e-06	6.03e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTP1—prostate cancer	9.98e-07	6e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ITPR1—prostate cancer	9.82e-07	5.91e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CD—prostate cancer	9.72e-07	5.84e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TYMS—prostate cancer	9.28e-07	5.58e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NOS3—prostate cancer	9.18e-07	5.52e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTM1—prostate cancer	9.17e-07	5.52e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LPL—prostate cancer	9e-07	5.41e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP1A1—prostate cancer	8.69e-07	5.23e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ERCC2—prostate cancer	8.62e-07	5.19e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CB—prostate cancer	8.47e-07	5.09e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS2—prostate cancer	8.39e-07	5.05e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTHFR—prostate cancer	8.11e-07	4.88e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARA—prostate cancer	7.95e-07	4.78e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CAV1—prostate cancer	7.48e-07	4.5e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTEN—prostate cancer	7.32e-07	4.4e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—EP300—prostate cancer	6.98e-07	4.2e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CG—prostate cancer	6.81e-07	4.1e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—INS—prostate cancer	6.45e-07	3.88e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CREBBP—prostate cancer	6.31e-07	3.8e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CD—prostate cancer	5.99e-07	3.6e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NOS3—prostate cancer	5.65e-07	3.4e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.22e-07	3.14e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS2—prostate cancer	5.17e-07	3.11e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CA—prostate cancer	5.16e-07	3.11e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTEN—prostate cancer	4.51e-07	2.71e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—EP300—prostate cancer	4.3e-07	2.59e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKT1—prostate cancer	4.22e-07	2.54e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.18e-07	1.91e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKT1—prostate cancer	2.6e-07	1.56e-05	CbGpPWpGaD
